indapamide has been researched along with indapamide, perindopril drug combination in 60 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 14 (23.33) | 29.6817 |
2010's | 43 (71.67) | 24.3611 |
2020's | 3 (5.00) | 2.80 |
Authors | Studies |
---|---|
Doucet, J; Guez, D; Henry, JP; Mulder, P; Richard, V; Schiavi, P; Thuillez, C | 1 |
Krzesinski, JM | 1 |
Boutouyrie, P; Laurent, S; Tropeano, AI | 1 |
Waeber, B | 1 |
Ruilope, LM; Segura, J | 1 |
Camici, PG | 1 |
Chalmers, J; Joshi, R; Kengne, AP; MacMahon, S | 1 |
Poulter, NR | 1 |
Le Jeune, S; Mourad, JJ | 1 |
Cass, A; Chalmers, J; de Galan, BE; Glasziou, P; Grobbee, D; Hamet, P; Harrap, S; Heller, S; Lisheng, L; MacMahon, S; Mancia, G; Marre, M; Neal, B; Ninomiya, T; Patel, A; Perkovic, V; Pillai, A; Poulter, N; Travert, F; Woodward, M; Zoungas, S | 1 |
Anderson, C; Chalmers, J; Cooper, M; de Galan, BE; Dufouil, C; Grobbee, DE; Hackett, M; Hamet, P; Heller, SR; Lisheng, L; MacMahon, S; Mancia, G; Neal, B; Pan, CY; Patel, A; Pillai, A; Poulter, N; Travert, F; Woodward, M; Zoungas, S | 1 |
Chen, JW; Huang, SS; Lin, SJ; Wu, TC | 1 |
Hara, K; Kadowaki, T | 1 |
Beckett, N; Bulpitt, C; Burch, L; de Vernejoul, MC; Duggan, J; Fletcher, A; Gil-Extremera, B; Liu, L; Peters, R; Swift, C | 1 |
Batty, GD; Chalmers, J; Czernichow, S; de Galan, BE; Hamet, P; Harrap, SB; Huxley, R; Li, Q; Neal, B; Patel, A; Poulter, N; Woodward, M; Zoungas, S | 1 |
Ghiadoni, L | 1 |
Pella, D | 1 |
Hamet, P | 1 |
Beulens, JW; Chalmers, J; Cooper, ME; Grobbee, DE; Harrap, S; Kengne, AP; Mancia, G; Neal, B; Patel, A; Poulter, N; van der Schouw, YT; van Dieren, S; Woodward, M; Zoungas, S | 1 |
Golubeva, LV; Logovikova, SI; Protasov, KV; Reshina, IV; Sinkevich, DA; Zhizhko, NV | 1 |
Karpov, IuA | 1 |
Davis, SN; Konig, M; Lamos, EM; Stein, SA | 1 |
Baleeva, LV; Galiavi, RA; Galiavich, AS | 1 |
Arima, H; Chalmers, J; Harrap, S; Hirakawa, Y; Mancia, G; Patel, A; Poulter, N; Williams, B; Woodward, M; Zoungas, S | 1 |
Bakris, GL; Yamout, H | 1 |
Farsang, C | 1 |
Blomster, JI; Chalmers, J; Chow, CK; Harrap, S; Hillis, GS; Li, Q; Mancia, G; Neal, B; Patel, A; Poulter, N; Williams, B; Woodward, M; Zoungas, S | 1 |
Tóth, K | 1 |
Arima, H; Chalmers, J; Cooper, M; Hamet, P; Harrap, S; Hirakawa, Y; Mancia, G; Ninomiya, T; Poulter, N; Woodward, M; Zoungas, S | 1 |
Banya, W; Beckett, N; Bulpitt, C; Duggan, J; Fagard, R; Fletcher, A; Leonetti, G; McCormack, T; Narkiewicz, K; Peters, R; Thijs, L | 1 |
Arima, H; Billot, L; Chalmers, J; Colagiuri, S; Cooper, ME; Glasziou, P; Grobbee, D; Hamet, P; Harrap, S; Heller, S; Hirakawa, Y; Joshi, R; Li, Q; Lisheng, L; MacMahon, S; Mancia, G; Marre, M; Matthews, DR; Mogensen, CE; Monaghan, H; Neal, B; Patel, A; Perkovic, V; Poulter, N; Rodgers, A; Williams, B; Woodward, M; Zoungas, S | 1 |
Chalmers, J; Glasziou, P; Grobbee, DE; Hamet, P; Kengne, AP; MacMahon, S; Poulter, N; van der Graaf, Y; van der Leeuw, J; Visseren, FL; Woodward, M; Zoungas, S | 1 |
Chalmers, J; Cooper, M; Grobbee, R; Hirakawa, Y; Jardine, M; Kengne, AP; Matthews, DR; Patel, A; Poulter, N; Woodward, M; Zoungas, S | 1 |
İnce, I; Karasulu, E; Ölçer, A; Ölçer, M | 1 |
Chalmers, J; Cooper, ME; Hamet, P; Harrap, S; Heller, S; Li, Q; MacMahon, S; Mancia, G; Marre, M; Matthews, D; Neal, B; Perkovic, V; Poulter, N; Rodgers, A; Williams, B; Wong, MG; Woodward, M; Zoungas, S | 1 |
Dézsi, CA; Nádházi, Z | 1 |
Chalmers, J; Harrap, S; Hirakawa, Y; Lisheng, L; Mancia, G; Marre, M; Mohammedi, K; Neal, B; Rodgers, A; Williams, B; Woodward, M; Zoungas, S | 1 |
Chalmers, J; Grobbee, DE; Harrap, S; Heller, S; Mancia, G; Marre, M; Poulter, N; van der Graaf, Y; van der Leeuw, J; Visseren, FL; Woodward, M; Zoungas, S | 1 |
Chalmers, J; Harrap, S; Li, Q; Marre, M; Mohammedi, K; Patel, A; Woodward, M; Zoungas, S | 1 |
Karpov, YA | 1 |
Atkins, ER; Chalmers, J; Cooper, M; Hamet, P; Harrap, S; Hirakawa, Y; Lees, K; Liu, L; Mancia, G; Marre, M; Perkovic, V; Poulter, N; Rodgers, A; Salam, A; Williams, B; Woodward, M | 1 |
Chumachek, EV; Hripaeva, VJ; Ledyaeva, AA; Nedogoda, SV; Palashkin, RV; Salasyuk, AS; Smirnova, VO; Tsoma, VV | 1 |
Deev, AD; Glezer, MG | 1 |
Chalmers, J; Colagiuri, S; Cooper, M; Harrap, S; Mancia, G; Marre, M; Mohammedi, K; Poulter, N; Williams, B; Woodward, M; Zoungas, S | 1 |
Glezer On Behalf Of The Forsage Program Participants, MG | 1 |
Lévy, BI; Taddei, S | 1 |
Chalmers, J; Colagiuri, S; Cooper, ME; DeVries, JH; Grobbee, DE; Hamet, P; Li, Q; Mancia, G; Marre, M; van Steen, SC; Williams, B; Woodward, M | 1 |
Chalmers, J; Coresh, J; Herrington, W; Li, Q; Mancia, G; Marre, M; Mohammedi, K; Perkovic, V; Poulter, N; Rodgers, A; Williams, B; Woodward, M | 1 |
Dézsi, CA; Farsang, C | 1 |
Kobalava, ZD; Tolkacheva, VV; Troitskaya, EA | 1 |
Chalmers, J; Cooper, ME; Glasziou, P; Hamet, P; Harrap, S; Jun, M; Mancia, G; Marre, M; Neal, B; Ohkuma, T; Perkovic, V; Poulter, N; Rodgers, A; Williams, B; Woodward, M; Zoungas, S | 1 |
Chalmers, J; Hamet, P; Harrap, S; Mancia, G; Marre, M; McEvoy, JW; Muntner, P; Ohkuma, T; Rahman, F; Rodgers, A; Selvin, E; Williams, B; Woodward, M | 1 |
Dehayem, MY; Etoa, M; Hamadou, B; Kaze, FF; Kengne, AP; Kouam, M; Mbanya, JC; Mfeukeu-Kuate, L; Nganou-Gnindjio, CN; Ngassam, E; Nkamgna, A; Sobngwi, E; Tankeu, AT | 1 |
Asmar, R; De Champvallins, M; Feldmann, L; Mourad, JJ; Topouchian, J | 1 |
Chalmers, J; Hamet, P; Harrap, S; Lee, AK; Marre, M; Mcevoy, JW; Ohkuma, T; Selvin, E; Sharrett, AR; Wang, D; Warren, B; Williams, B; Woodward, M | 1 |
Lenti, S; Mazza, A; Rigatelli, G; Rossetti, C; Rubello, D; Schiavon, L; Torin, G; Townsend, DM | 1 |
Chalmers, J; Cooper, M; Harrap, S; Mancia, G; Ohkuma, T; Poulter, N; Tian, J; Wang, JG; Woodward, M; Zoungas, S | 1 |
Kochetkov, AI; Ostroumova, OD; Ostroumova, TM; Parfenov, VA; Perepelov, VA; Perepelova, EM | 1 |
10 review(s) available for indapamide and indapamide, perindopril drug combination
Article | Year |
---|---|
Pulse pressure reduction and cardiovascular protection.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Clinical Trials as Topic; Diuretics; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril | 2006 |
Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diuretics; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril; Vascular Diseases | 2006 |
Renal protection in diabetic patients: benefits of a first-line combination of perindopril-indapamide (Preterax).
Topics: Albuminuria; Antihypertensive Agents; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril | 2006 |
From microcirculation to cardiac event: protection with Preterax.
Topics: Antihypertensive Agents; Cardiotonic Agents; Coronary Artery Disease; Drug Combinations; Humans; Hypertension, Renal; Indapamide; Microcirculation; Perindopril | 2008 |
Evaluation of high dose of perindopril/indapamide fixed combination in reducing blood pressure and improving end-organ protection in hypertensive patients.
Topics: Antihypertensive Agents; Blood Pressure; Cytoprotection; Dose-Response Relationship, Drug; Drug Combinations; Humans; Hypertension; Indapamide; Kidney; Kidney Diseases; Perindopril; Randomized Controlled Trials as Topic; Titrimetry; Treatment Outcome | 2009 |
Perindopril for the treatment of hypertension.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Dose-Response Relationship, Drug; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril | 2011 |
What matters in ADVANCE and ADVANCE-ON.
Topics: Antihypertensive Agents; Biomarkers; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Drug Combinations; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemic Agents; Incidence; Indapamide; Kidney Failure, Chronic; Multicenter Studies as Topic; Perindopril; Randomized Controlled Trials as Topic; Risk Factors | 2012 |
An insight into the recent diabetes trials: what is the best approach to prevent macrovascular and microvascular complications?
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Combinations; Gliclazide; Glycated Hemoglobin; Humans; Indapamide; Perindopril; United Kingdom | 2013 |
The Results of ACES (Antihypertensive Combinations' Long Term Efficacy Comparing Study): Analysis of Metabolic Effects of Antihypertensive Combination Therapies.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Carbazoles; Carvedilol; Diuretics; Drug Combinations; Essential Hypertension; Female; Humans; Hypertension; Indapamide; Lipoproteins, LDL; Male; Middle Aged; Perindopril; Propanolamines; Prospective Studies; Risk Factors | 2016 |
Vascular legacy beyond blood pressure control: benefits of perindopril/indapamide combination in hypertensive patients with diabetes.
Topics: Antihypertensive Agents; Blood Circulation; Diabetes Mellitus, Type 2; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril | 2018 |
25 trial(s) available for indapamide and indapamide, perindopril drug combination
Article | Year |
---|---|
Blood pressure lowering with fixed combination perindopril-indapamide: key findings from ADVANCE.
Topics: Aged; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Combinations; Female; Follow-Up Studies; Humans; Hypertension, Renal; Indapamide; Male; Middle Aged; Perindopril; Placebos; Treatment Outcome | 2008 |
Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.
Topics: Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Combinations; Drug Therapy, Combination; Female; Gliclazide; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Male; Microcirculation; Middle Aged; Perindopril; Placebos | 2009 |
Combination of an ACE inhibitor and indapamide improves blood pressure control, but attenuates the beneficial effects of ACE inhibition on plasma adiponectin in patients with essential hypertension.
Topics: Adiponectin; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Blood Glucose; Blood Pressure; Cilazapril; Diuretics; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Indapamide; Insulin; Lipids; Male; Middle Aged; Perindopril; Pilot Projects; Time Factors; Treatment Outcome | 2009 |
The effect of treatment based on a diuretic (indapamide) +/- ACE inhibitor (perindopril) on fractures in the Hypertension in the Very Elderly Trial (HYVET).
Topics: Aged, 80 and over; Aging; Antihypertensive Agents; Blood Pressure; Drug Combinations; Female; Fractures, Bone; Humans; Hypertension; Incidence; Indapamide; Male; Perindopril; Placebos; Risk Factors | 2010 |
Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Erectile Dysfunction; Follow-Up Studies; Gliclazide; Humans; Hypoglycemic Agents; Indapamide; Male; Middle Aged; Perindopril; Prospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2010 |
Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Odds Ratio; Perindopril; Risk Factors; Treatment Outcome | 2012 |
Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the Action In Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) trial.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dihydropyridines; Drug Combinations; Drug Therapy, Combination; Female; Gliclazide; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Male; Middle Aged; Perindopril; Proportional Hazards Models | 2014 |
The relationship between alcohol consumption and vascular complications and mortality in individuals with type 2 diabetes.
Topics: Aged; Alcohol Drinking; Antihypertensive Agents; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Drug Combinations; Female; Gliclazide; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Male; Myocardial Infarction; Perindopril; Retrospective Studies; Risk Reduction Behavior; Stroke | 2014 |
Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial.
Topics: Aged; Aged, 80 and over; Blood Glucose; Cause of Death; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Combinations; Female; Follow-Up Studies; Gliclazide; Humans; Hypoglycemic Agents; Indapamide; Male; Middle Aged; Office Visits; Perindopril; Risk Factors | 2014 |
Subgroup and per-protocol analyses from the Hypertension in the Very Elderly Trial.
Topics: Age Factors; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Perindopril; Risk Assessment; Stroke | 2014 |
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes.
Topics: Antihypertensive Agents; Blood Glucose; Diabetes Mellitus, Type 2; Drug Combinations; Female; Follow-Up Studies; Gliclazide; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Male; Middle Aged; Perindopril; Risk Factors | 2014 |
Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus: results from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation.
Topics: Aged; Antihypertensive Agents; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug Combinations; Female; Follow-Up Studies; Gliclazide; Humans; Hypoglycemic Agents; Indapamide; Male; Perindopril; Risk Factors; Time Factors; Treatment Outcome | 2015 |
The advantages of combination therapy on hypertension: development of immediate release perindopril-indapamide tablet and assessment of bioequivalence studies.
Topics: Administration, Oral; Adult; Angiotensin-Converting Enzyme Inhibitors; Area Under Curve; Chemistry, Pharmaceutical; Cross-Over Studies; Drug Combinations; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Tablets; Therapeutic Equivalency; Young Adult | 2016 |
Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON.
Topics: Aged; Antihypertensive Agents; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Drug Combinations; Female; Follow-Up Studies; Gliclazide; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Indapamide; Kidney Failure, Chronic; Male; Middle Aged; Perindopril; Treatment Outcome | 2016 |
Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes.
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Drug Combinations; Endpoint Determination; Female; Follow-Up Studies; Gliclazide; Glycated Hemoglobin; Humans; Indapamide; Male; Middle Aged; Perindopril; Peripheral Arterial Disease; Proportional Hazards Models; Risk Factors | 2016 |
Absence of Peripheral Pulses and Risk of Major Vascular Outcomes in Patients With Type 2 Diabetes.
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diagnostic Techniques, Cardiovascular; Disease Progression; Drug Combinations; Female; Gliclazide; Humans; Hypoglycemic Agents; Indapamide; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Perindopril; Pulse; Risk Factors; Stroke | 2016 |
Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.
Topics: Aged; Antihypertensive Agents; Diabetes Complications; Diabetes Mellitus, Type 2; Drug Combinations; Female; Gliclazide; Glycosylation; Hemoglobins; Humans; Hypoglycemic Agents; Indapamide; Male; Microcirculation; Middle Aged; Perindopril; Proportional Hazards Models; Risk; Treatment Outcome; Vascular Diseases | 2018 |
Associations between body mass index and the risk of renal events in patients with type 2 diabetes.
Topics: Aged; Albuminuria; Blood Glucose; Body Mass Index; Creatinine; Diabetes Mellitus, Type 2; Drug Combinations; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Indapamide; Kidney; Kidney Diseases; Male; Middle Aged; Obesity; Overweight; Perindopril; Reference Values; Renal Insufficiency | 2018 |
Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Combinations; Drug Monitoring; Female; Humans; Indapamide; Male; Medication Therapy Management; Middle Aged; Perindopril; Risk Assessment; Treatment Outcome; Withholding Treatment | 2019 |
Effects of Blood Pressure Lowering on Clinical Outcomes According to Baseline Blood Pressure and Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Combinations; Female; Follow-Up Studies; Global Health; Humans; Incidence; Indapamide; Male; Middle Aged; Perindopril; Risk Factors; Survival Rate; Treatment Outcome | 2019 |
Short-term effects of perindopril-amlodipine vs perindopril-indapamide on blood pressure control in sub-Saharan type 2 diabetic individuals newly diagnosed for hypertension: A double-blinded randomized controlled trial.
Topics: Africa South of the Sahara; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Comorbidity; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Combinations; Drug Monitoring; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Treatment Outcome | 2019 |
The Risks of Cardiovascular Disease and Mortality Following Weight Change in Adults with Diabetes: Results from ADVANCE.
Topics: Adult; Aged; Body-Weight Trajectory; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug Combinations; Female; Follow-Up Studies; Gliclazide; Humans; Hypertension; Indapamide; Life Style; Male; Middle Aged; Obesity; Overweight; Perindopril; Risk Factors; Weight Gain; Weight Loss | 2020 |
Long-term effect of the perindopril/indapamide/amlodipine single-pill combination on left ventricular hypertrophy in outpatient hypertensive subjects.
Topics: Amlodipine; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Female; Follow-Up Studies; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Male; Middle Aged; Outpatients; Perindopril; Systole; Time Factors | 2019 |
Effects of Intensive Glycemic Control on Clinical Outcomes Among Patients With Type 2 Diabetes With Different Levels of Cardiovascular Risk and Hemoglobin A
Topics: Aged; Blood Glucose; Cardiovascular Diseases; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Combinations; Female; Gliclazide; Glycated Hemoglobin; Glycemic Control; Heart Disease Risk Factors; Humans; Hypoglycemic Agents; Indapamide; Male; Middle Aged; Perindopril; Prognosis; Risk Factors; Treatment Outcome | 2020 |
Effect of Perindopril/Indapamide on Cerebral Blood Flow in Middle-Aged, Treatment-Naïve Patients with Hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cerebrovascular Circulation; Drug Combinations; Essential Hypertension; Female; Humans; Hypertension; Indapamide; Magnetic Resonance Imaging; Male; Middle Aged; Perindopril | 2020 |
25 other study(ies) available for indapamide and indapamide, perindopril drug combination
Article | Year |
---|---|
Effects of combination of low doses of angiotensin-converting enzyme inhibitor and diuretics on renal function in spontaneously hypertensive rats: comparison between acute and chronic treatment.
Topics: Animals; Antihypertensive Agents; Diuresis; Diuretics; Dose-Response Relationship, Drug; Drug Combinations; Hypertension; Indapamide; Kidney; Natriuresis; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2001 |
[The drug of the month: a new antihypertensive association: Preterax, low doses of ACE inhibitor and thiazide in the same pill].
Topics: Drug Combinations; Humans; Hypertension; Indapamide; Perindopril; Remission Induction; Time Factors | 2004 |
[Results of ADVANCE trial conducted in type 2 diabetic patients].
Topics: Cardiovascular Diseases; Congresses as Topic; Diabetes Mellitus, Type 2; Drug Combinations; Europe; Humans; Indapamide; Microcirculation; Multicenter Studies as Topic; Perindopril; Randomized Controlled Trials as Topic; Societies, Medical; Survival Rate | 2008 |
Blood pressure and glucose control in subjects with diabetes: new analyses from ADVANCE.
Topics: Aged; Antihypertensive Agents; Blood Glucose; Blood Pressure; Diabetes Complications; Diabetes Mellitus, Type 2; Drug Combinations; Female; Gliclazide; Humans; Hypoglycemic Agents; Indapamide; Male; Middle Aged; Perindopril; Randomized Controlled Trials as Topic | 2009 |
Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.
Topics: Aged; Antihypertensive Agents; Cognition; Cognition Disorders; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Combinations; Drug Therapy, Combination; Educational Status; Female; Gliclazide; Humans; Hypoglycemia; Hypoglycemic Agents; Indapamide; Male; Mental Status Schedule; Myocardial Infarction; Perindopril; Risk Factors; Stroke | 2009 |
How controlling of hypertension might matter.
Topics: Adiponectin; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Blood Glucose; Blood Pressure; Cilazapril; Diuretics; Drug Combinations; Humans; Hypertension; Indapamide; Insulin; Lipids; Perindopril; Time Factors; Treatment Outcome | 2009 |
[Blood pressure therapy - differential therapeutic solutions. Fixed combination improves prognosis of hypertensive patients].
Topics: Antihypertensive Agents; Clinical Trials as Topic; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril | 2011 |
Efficacy and safety of treatment of hypertensive patients with fixed combination perindopril/indapamide up to 10/2.5 mg: results of the FALCO FORTE programme.
Topics: Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Chi-Square Distribution; Diuretics; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Prospective Studies; Quality of Life; Risk Assessment; Risk Factors; Slovakia; Time Factors; Treatment Outcome | 2011 |
[Vascular effects of perindopril arginine and indapamide fixed combination in patients with arterial hypertension].
Topics: Administration, Oral; Antihypertensive Agents; Arteries; Biological Availability; Blood Pressure; Drug Combinations; Drug Synergism; Endothelium, Vascular; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Pulse Wave Analysis; Treatment Outcome; Vascular Resistance; Vasodilation | 2012 |
[The FORTISSIMO program: advantages of fixed full dose combination of perindopril arginine and indapamide in the treatment of poorly controlled arterial hypertension].
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Disease Management; Dose-Response Relationship, Drug; Drug Combinations; Drug Monitoring; Drug Resistance; Female; Humans; Hypertension; Indapamide; Male; Medication Adherence; Middle Aged; Perindopril; Program Development; Prospective Studies; Risk Factors; Russia; Treatment Outcome | 2013 |
[Regional results of the program FORTISSIMO in Kazan].
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Drug Combinations; Drug Monitoring; Drug Resistance; Female; Humans; Hypertension; Indapamide; Male; Medication Adherence; Middle Aged; Perindopril; Program Development; Prospective Studies; Risk Factors; Russia; Treatment Outcome | 2013 |
Evidence-based triple antihypertensive therapy yields lower mortality in older patients with diabetes mellitus.
Topics: Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dihydropyridines; Drug Combinations; Female; Gliclazide; Humans; Hypertension; Indapamide; Male; Perindopril | 2014 |
Efficacy and tolerability of fixed-dose combination of perindopril/indapamide in type 2 diabetes mellitus: PICASSO trial.
Topics: Aged; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Diabetes Mellitus, Type 2; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Prediabetic State; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2014 |
Antihypertensive efficacy of triple combination perindopril/indapamide plus amlodipine in high-risk hypertensives: results of the PIANIST study (Perindopril-Indapamide plus AmlodipiNe in high rISk hyperTensive patients).
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Prospective Studies; Risk Factors | 2014 |
Prediction of 10-year vascular risk in patients with diabetes: the AD-ON risk score.
Topics: Aged; Antihypertensive Agents; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Combinations; Drug Therapy, Combination; Female; Gliclazide; Health Status Indicators; Humans; Hypoglycemic Agents; Indapamide; Male; Middle Aged; Perindopril; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors | 2016 |
Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes.
Topics: Aged; Antihypertensive Agents; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug Combinations; Female; Gliclazide; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Indapamide; Male; Middle Aged; Perindopril; Precision Medicine; Risk Factors; Risk Reduction Behavior | 2016 |
Full-dose Perindopril/Indapamide in the Treatment of Difficult-to-Control Hypertension: The FORTISSIMO Study.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Drug Combinations; Drug Resistance; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Prospective Studies; Treatment Outcome | 2017 |
Side effects and tolerability of combination blood pressure lowering according to blood pressure levels: an analysis of the PROGRESS and ADVANCE trials.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Drug Combinations; Female; Humans; Hypertension; Hypotension; Indapamide; Male; Medication Adherence; Middle Aged; Multicenter Studies as Topic; Perindopril; Placebos; Proportional Hazards Models; Randomized Controlled Trials as Topic; Stroke | 2017 |
[Optimization of Control of Blood Pressure, Metabolic Disorders and Target Organs Protection With Fixed Perindopril and Indapamide Combination in Treated Patients With Arterial Hypertension].
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Humans; Hypertension; Indapamide; Metabolic Diseases; Perindopril; Pulse Wave Analysis | 2017 |
[How to Increase the Effectiveness of Antihypertensive Therapy in Clinical Practice: Results of the Russian Observational Program FORSAZH].
Topics: Antihypertensive Agents; Blood Pressure; Drug Combinations; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Russia | 2016 |
Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Combinations; Female; Gliclazide; Humans; Hypoglycemic Agents; Indapamide; Male; Microvessels; Middle Aged; Perindopril; Risk Factors; Treatment Outcome | 2017 |
[Adherence of Patients to Antihypertensive Therapy With Combination of Perindopril and Indapamide According to Data of the FORSAGE Program].
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Medication Adherence; Perindopril; Stroke | 2017 |
Efficacy and Tolerability of Fixed-Dose Combination Perindopril/Indapamide in Hypertensive Patients with a History of Stroke or Transient Ischemic Attack: PICASSO Trial.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Female; Humans; Hungary; Hypertension; Indapamide; Ischemic Attack, Transient; Male; Middle Aged; Perindopril; Stroke; Treatment Outcome | 2018 |
[Combined Therapy of Arterial Hypertension With Triple Fixed-Dose Combination of Amlodipine/Indapamide/Perindopril Arginine in Real Clinical Practice: the Organization and the Main Results of the DOKAZATEL'STVO (Proof) Study].
Topics: Academic Medical Centers; Aged; Amlodipine; Antihypertensive Agents; Arginine; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Patient Compliance; Perindopril; Russia | 2018 |
Feasibility of 24-h central blood pressure monitoring: experience from multinational clinical trial assessing the efficacy of perindopril/indapamide/amlodipine.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Feasibility Studies; Humans; Hypertension; Indapamide; Perindopril; Randomized Controlled Trials as Topic | 2019 |